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ABSTRACT
Context: World kidney day is a yearly global alertness and education ceremony, held on the 
second Thursday in March. 
Evidence Acquisition: Directory of  open access journals (DOAJ), EMBASE, Google Scholar, 
PubMed, EBSCO, and Web of  Science have been searched.
Results: Once again we reached to March 14, the world kidney day of  2016. This is the 10th 
anniversary of  world kidney day, a program of  the International Society of  Nephrology 
(ISN) and the International Federation of  Kidney Foundations (IFKF). World kidney day 
first began in 2006 and the worldwide campaign highlights a specific theme each year. The 
theme for 2015 was to invite everybody to drink a glass of  water and give one, too, to 
celebrate their kidneys. This is a symbolic action to memorize that kidneys are vital organs 
and that they might be cared. 
Conclusions: It is a manner to make individuals more conscious about their lifestyle choices. 
In this year, world kidney day will be celebrated on Thursday March 10, 2016. The theme 
for 2016 will highlight on renal disease and children. 
Implication for health policy/practice/research/medical education:
World kidney day is a yearly global alertness and education ceremony, held on the second Thursday in March. 
In 2016, world kidney day will be celebrated on Thursday March 10, 2016. The theme for 2016 will highlight on 
renal disease and children. The general message of  world kidney day 2016 is “a collaborative modality against the 
renal diseases in children that lead to end-stage renal failure, through increasing community outreach, improved 
economic opportunity, better education, and having access to preventive strategies for individuals at highest risk.” 
These could end the unfavorable relationship between chronic renal failure and high risk populations.
Please cite this paper as: Nasri H, Rafieian-Kopaei M. On the occasion of  world kidney day 2016; work together to 
better protect the kidney. J Nephropathol. 2016;5(1):15-18. DOI: 10.15171/jnp.2016.03
1. Context
World kidney day is a yearly global alertness and 
education ceremony, held on the second Thursday in 
March. Once again we reached to March, the world 
kidney day of  2016 (1-3). In this year, world kidney 
day will be celebrated on Thursday March 10, 2016. 
The theme for 2016 will highlight on renal disease and 
children (2-4). 
This is the 10th anniversary of  world kidney day, a 
program of  the International Society of  Nephrology 
(ISN) and the International Federation of  Kidney 
Foundations (IFKF). World kidney day first began 
in 2006 and the worldwide campaign highlights a 
specific theme each year, and the theme for 2015 is 
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to invite everybody to drink a glass of  water and give 
one, too, to celebrate their kidneys. In fact, this is a 
symbolic action to memorize that kidneys are vital 
organs and that they might be cared. It is a manner to 
make individuals more conscious about their lifestyle 
choices (3-8).
2. Evidence Acquisition
For this review, we used a variety of  sources by 
searching through PubMed/Medline, Scopus, 
EMBASE, EBSCO and directory of  open access 
journals (DOAJ). The search was conducted, using 
combinations of  the following key words and or their 
equivalents; chronic renal failure, world kidney day, 
acute kidney injury and renoprotection.
3. Results
3.1. The history of  world kidney day
From its beginning in 2006, world kidney day has 
become the most successful attempt to raise alertness 
amongst the general public and decision-makers about 
the significance of  renal disease. Every year world 
kidney day reminds us that renal disease is common, 
harmful and also treatable (1-4). In this day, national 
and countless local events are organized by renal 
charities, healthcare professionals, patient groups 
and persons who wish to make a difference. We are 
encouraging everybody to get behind the campaign 
and endeavor to organize an activity or event to 
celebrate world kidney day and draw public notice 
to the need for renal healthiness, what can be done 
to save kidneys before disease strikes, and to help 
patients who previously have chronic renal failure. In 
fact, this day, provides the ideal opportunity to get out 
in the community and distribute the world kidney day 
message with family, friends and population you meet 
(2-5). In 2013, the theme of  world kidney day was 
to increase awareness on acute kidney injury in both 
developed and developing countries (5-8). 
3.2. Acute kidney injury may progress to chronic kidney disease
Acute kidney injury is defined by sudden decrease in 
kidney function through diminution of  glomerular 
filtration rate, resulting in accumulation of  nitrogenous 
waste products and electrolyte and fluid imbalance 
(8-10). This situation is frequently accompanied 
by decreased urine output and is highly associated 
with increased early and long-term mortality and 
morbidity. Notably also, there is consequently a risk 
for the progression to chronic kidney disease. In 
2014, the aim of  world kidney day was to increase 
awareness on chronic renal failure and aging (2-5). 
Chronic renal failure is characterized by slow loss of 
kidney function over time (7-9). Over the last decade, 
awareness on the incidence, rate of  progression, risk 
factors and clinical outcomes of  chronic renal failure 
has been growing as a result of  high prevalence and 
rising awareness of  chronic renal failure (3-9). In early 
stages of  chronic kidney disease (CKD), patients are 
frequently asymptomatic (2-7). Although it could 
be asymptomatic, chronic renal failure negatively 
affects several organs, raises the risk of  cardiovascular 
diseases and can progress to end-stage renal disease, 
and eventually increases the risk of  hospitalization 
and death (9-12). There is an increasing prevalence 
of  end-stage renal disease globally (11,12). The 
increase in prevalence of  end-stage renal failure 
continues despite at least two decades of  intensified 
renal protection programs including optimal blood 
pressure control, suitable glycemic control in diabetic 
patients, smoking cessation (5-9), and the broad use 
of  angiotensin converting enzyme inhibitors or renin-
angiotensin-aldosterone system blockers in both non-
diabetic and diabetic chronic renal failure (9-14). 
It is noteworthy to remember that the incidence 
of  acute kidney injury and CKD has been growing 
over time. Though acute kidney injury has long been 
thought to be completely reversible disease, but, over 
the past several years, various data from experimental 
investigations and human studies have been published 
and pointed out that acute kidney injury can result 
in permanent kidney damage and progress to CKD 
(12-16). Additionally, the chance of  patient survival 
after acute kidney injury has also been increasing over 
time (3,6-9). Hence, if  acute kidney injury actually 
increases the risk for CKD, then it could delineate a 
noteworthy public health concern with attention to the 
percentage of  individuals developing incident CKD, 
and end-stage kidney failure (14-19). The existing 
thought is that chronic renal disease will progress to 
end-stage renal disease or death at an increasing rate 
and progression from renal parenchymal damage to 
end-stage renal failure is the final common way for 
chronic nephropathies, which seems to be mainly 
independent of  the initial kidney insult (14-19). 
3.3. The concept of  renoprotection
Each kidney has about one million tiny filters, called 
nephrons. If  nephrons are injured, they will stop 
working. For an instance, healthy nephrons can take 
on the extra work. However, if  the injury continues, 
more and more nephrons will be destroyed. After 
a certain point, the nephrons that are left may not 
filter the blood toxins well enough to maintain 
the homeostasis (12-19). At this time, there is an 
increased glomerular capillary pressure, which 
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disturbs glomerular impermeability to proteins and 
lets an excessive quantity of  protein to reach the renal 
proximal tubules. Subsequently, tubular reabsorption 
of  filtered protein, results to renal interstitial injury 
by activating intracellular mechanisms, including 
up-regulation of  the genes encoding vasoactive and 
several inflammatory mediators. At this stage, chronic 
renal failure as a progressive loss of  kidney function 
over a period of  months to years will ensue (8-14). 
However, various modalities have been proposed 
to delay the progression of  renal failure. Renal 
interstitial inflammation and progression of  disease 
can be delayed by angiotensin receptor blockade or 
angiotensin-converting enzyme inhibition which 
intensify the glomerular impermeability barrier to 
proteins and hence limit proteinuria and the filtered 
protein-dependent various inflammatory signals (7-
15). Tubules can be protected by various natural or 
synthetic antioxidants against reactive oxygen species 
and various injurious insults which may result in 
tubular cell apoptosis and death and subsequent 
aggravation of  renal failure (14-18). 
Recently, much attention has been directed toward 
the concept of  renoprotection by pursuing the above 
mentioned modalities to delay the progression of 
CKD. Fortunately, several clinical and experimental 
observations brightly imply that remission can now 
be achieved in some patients with chronic renal 
failure (18-24). It is clear that the proximal tubular 
epithelial cell is able to have a pro-fibrotic and pro-
inflammatory role during proteinuria in which the 
proximal renal tubular epithelial cell expresses several 
chemokines and injury signals which result in extensive 
renal tubular atrophy, interstitial inflammation and 
eventually fibrosis (17-25).
More recently several studies have detected that chronic 
renal failure is a common condition which stimulates 
the cellular senescence and premature aging via toxic 
alterations in the internal milieu. This happens by 
some mechanisms, including DNA and mitochondrial 
injury, stem cell exhaustion, increased reactive oxygen 
species generation, phosphate toxicity and persistent 
inflammation, as well as telomere attrition. Moreover, 
in the process of  various nephropathies, capillary 
rarefaction leads to local renal ischemia with further 
injury to the renal tubules, matrix protein deposition, 
presence of  more profibrogenic mediators, fibrosis, 
and finally worsening the glomerulosclerosis (19-
25). Therefore, in chronic renal failure, the tubules 
show various changes which are usually correlated 
with glomerular alterations, tubular cell degeneration, 
tubular apoptosis, and finally tubular atrophy (18-22). 
Therefore, it is reasonable to presume that we should 
provide tubular cell protection by using effective 
antioxidants (20-26). Moreover, administration of 
angiotensin converting enzyme inhibitors or renin-
angiotensin-aldosterone system blockades or even a 
combination of  them in appropriate patients in both 
non-diabetic and diabetic CKD. Additionally, control 
of  blood glucose in diabetes and high blood pressure 
in hypertensive individuals is of  utmost importance. 
These two diseases are the most leading causes of 
chronic renal failure and their incidence is growing at 
an alarming rate (23-26). 
One of  the important missions of  world kidney 
day 2015 was to increase awareness on CKD in 
disadvantaged populations. Indeed, the increased 
burden of  chronic renal failure in deprived populations 
is due to both universal factors and population specific 
issues (1-4). Low socioeconomic condition and poor 
access to care attributed to health care inequalities 
aggravate the negative impacts of  genetic or biologic 
predisposition. Provision of  suitable kidney care 
to these peoples requires providing facilities to the 
reach of  dialysis by development of  various low-
cost alternatives and also providing facilities for renal 
transplantation (1-7). 
3.4. The mission of  world kidney day over years
The mission of  world kidney day is to grow the 
awareness related to the kidney so that everyone cares 
for their kidneys and, if  appropriate, have check-up 
to examine whether they are at risk for renal disease. 
Prevention of  renal disease, early recognition, and 
subsequent renal protection are critical purposes for 
world kidney day (1-4). On the other hand, the global 
population is aging, and the number of  persons above 
85 years of  age is developing faster than any other 
age group (3-8). As the population continues to age, 
physicians receive growing number of  older patients 
with chronic renal failure and therefore, kidney failure 
would be a global challenge as a non-communicable 
epidemic (1-8). 
4. Conclusions
The general message of  world kidney day 2016 is “a 
collaborative modality against the renal diseases in 
children that lead to end-stage renal failure, through 
increasing community outreach, improved economic 
opportunity, better education, and having access to 
preventive strategies for individuals at highest risk.” 
These could end the unfavorable relationship between 
chronic renal failure and high risk populations.
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